BRCA2 mutations in primary breast and ovarian cancers.
Lancaster, J.M., Wooster, R., Mangion, J., Phelan, C.M., Cochran, C., Gumbs, C., Seal, S., Barfoot, R., Collins, N., Bignell, G., Patel, S., Hamoudi, R., Larsson, C., Wiseman, R.W., Berchuck, A., Iglehart, J.D., Marks, J.R., Ashworth, A., Stratton, M.R., Futreal, P.A.
Notes: The protein truncation test was performed on PCR products from the BRCA2 gene. The PCR products were used in the TNT® T7 Coupled Reticulocyte Lysate System to express the protein, and the protein was analyzed by SDS-PAGE. (0834)
Expand Full Notes »